HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Cavanagh, D. Articles by Davis, P. J. Search for Related Content PubMed PubMed Citation Articles by Cavanagh, D. Articles by Davis, P. J. Agricola Articles by Cavanagh, D. Articles by Davis, P. J.

Coronavirus IBV: Removal of Spike Glycopolypeptide S1 by Urea Abolishes Infectivity and Haemagglutination but Not Attachment to Cells

Houghton Poultry Research Station, Houghton, Huntingdon, Cambs. PE17 2DA, U.K.

Urea has been used to remove the S1 spike glycopolypeptide from avian infectious bronchitis virus (IBV) strains M41 and Beaudette, without removing the S2 spike-anchoring glycopolypeptide. Reduction of the pH to 2·9 did not cause release of S1 although some S1 was released spontaneously from IBV Beaudette at pH 7·4. Virus that lacked S1 was no longer infectious or able to cause haemagglutination (HA). However, radiolabelled IBV that lacked S1 attached to erythrocytes and chick kidney cells to the same or similar extent as did intact virus. Treatment of IBV with a phospholipase C preparation, required to make IBV cause HA, did not increase binding of IBV to erythrocytes. The results indicate that while the attachment to cells of virus that lacks S1 is qualitatively different from that of intact virus, the decline in infectivity is the consequence of the loss of some other spike function.

Keywords: coronavirus IBV, avian IBV, spike protein, cell attachment

Received 6 January 1986; accepted 8 April 1986.

This article has been cited by other articles:

				V. C. Chu, L. J. McElroy, V. Chu, B. E. Bauman, and G. R. Whittaker The Avian Coronavirus Infectious Bronchitis Virus Undergoes Direct Low-pH-Dependent Fusion Activation during Entry into Host Cells. J. Virol., April 1, 2006; 80(7): 3180 - 3188. [Abstract] [Full Text] [PDF]

				B. Sainz Jr., J. M. Rausch, W. R. Gallaher, R. F. Garry, and W. C. Wimley Identification and Characterization of the Putative Fusion Peptide of the Severe Acute Respiratory Syndrome-Associated Coronavirus Spike Protein J. Virol., June 1, 2005; 79(11): 7195 - 7206. [Abstract] [Full Text] [PDF]

				T. Hodgson, R. Casais, B. Dove, P. Britton, and D. Cavanagh Recombinant Infectious Bronchitis Coronavirus Beaudette with the Spike Protein Gene of the Pathogenic M41 Strain Remains Attenuated but Induces Protective Immunity J. Virol., December 15, 2004; 78(24): 13804 - 13811. [Abstract] [Full Text] [PDF]

				D. Yoo and D. Deregt A Single Amino Acid Change within Antigenic Domain II of the Spike Protein of Bovine Coronavirus Confers Resistance to Virus Neutralization Clin. Vaccine Immunol., March 1, 2001; 8(2): 297 - 302. [Abstract] [Full Text] [PDF]

				G. Wang, C. Deering, M. Macke, J. Shao, R. Burns, D. M. Blau, K. V. Holmes, B. L. Davidson, S. Perlman, and P. B. McCray Jr. Human Coronavirus 229E Infects Polarized Airway Epithelia from the Apical Surface J. Virol., October 1, 2000; 74(19): 9234 - 9239. [Abstract] [Full Text]